Plunkett Research Online: Provectus Biopharmaceuticals Inc

PROVECTUS BIOPHARMACEUTICALS INC (PVCT:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is focusing on developing minimally invasive products for the treatment of psoriasis and other topical diseases, and certain forms of cancer including recurrent breast carcinoma, metastatic melanoma, and liver cancer......



Provectus Biopharmaceuticals Inc
Ticker: PVCT
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 866 594-5999
Fax: 866 998-0005
Address: 10025 Investment Drive
Suite 250
Knoxville, TN 37932 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
John GlassCFO
Peter CulpepperChief Accounting Officer/COO/Secretary/CEO
See More
Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is focusing on developing minimally invasive products for the treatment of psoriasis and other topical diseases, and certain forms of cancer including recurrent breast carcinoma, metastatic melanoma, and liver cancer......See More See More

Auditor: Marcum LLP
Legal Advisor: Baker Donelson Bearman Caldwell & Berkowitz
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: